Trisha Gomez
Cardiovascular Disease · Saint Joseph, MINPI 1780170506
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.5%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Abbott at 52.6% of the total. 2025 is the largest year on record at $8,384, 7.4 times the $1,133 reported in 2022.
Across 158 payments — averaging $118.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Medtronic$4K
- Abiomed$1K
- Boston Scientific$1K
- Shockwave Medical, Inc$571
- E.r. Squibb & Sons, L.L.C.$392
- plus $2K from 20 others
What the payments were for
- Grants$3,00016%
- Travel & lodging$7,26939%
- Food & beverage$7,79342%
- Education$7084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 62 | $9,880 |
| Medtronic | 7 | $3,678 |
| Abiomed | 16 | $1,365 |
| Boston Scientific | 10 | $1,298 |
| Shockwave Medical, Inc | 11 | $571 |
| E.r. Squibb & Sons, L.L.C. | 12 | $392 |
| Heartflow, Inc. | 6 | $289 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $252 |
| Kestra Medical Technology Services, Inc. | 5 | $173 |
| Penumbra, Inc. | 2 | $167 |
| Boehringer Ingelheim | 2 | $116 |
| Bard Peripheral Vascular, Inc. | 1 | $114 |
| Philips North America LLC | 1 | $89 |
| Baxter Healthcare | 1 | $56 |
| Atricure, Inc. | 2 | $50 |
| Bridgebio Pharma, Inc. | 2 | $43 |
| Irhythm Technologies, Inc. | 2 | $40 |
| Chiesi USA, Inc. | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Amgen | 1 | $30 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $18 |
| Terumo Medical Corporation | 1 | $15 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$3,096
- PROSTAR$2,210
- PERCLOSE PROGLIDE$1,429
- Impella$937
- GENERAL - THERAPIES$894
- JOT DX$418
- ONYX FRONTIER$401
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$358
- ENSITE$266
- ESPRIT$169
- COREVALVE EVOLUT R$153
- SUPERA$147
- FFRct$147
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$139
- ENSITE PRECISION$135
- COROFLOW$130
- CAMZYOS$128
- CARDIOMEMS$128
- Indigo System$124
- RotarexS 6 F x 135 cm$114
How this compares
$18,770 in reported general payments places this provider in the 85th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $57,013 |
| Repatha SureclickEvolocumab | 13 | $6,629 |
| Metoprolol Succinate | 41 | $1,217 |
| Rosuvastatin Calcium | 41 | $1,065 |
| Ezetimibe | 14 | $681 |
| Atorvastatin Calcium | 22 | $444 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $261 |
| Amlodipine Besylate | 17 | $222 |
| Furosemide | 14 | $90 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Saint Joseph
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.